Hand tumorsare many and varied, although benign tumors are common. The pathology and histology of these tumors are not unlike these characteristics of the tumor when it occurs elsewhere. Early diagnosis and proper treatment of all hand tumors have been emphasized since the growth of tumors and pain can cause disturbance of intrinsic function of the hand. For the period of 10 years from 1977 to 1986, 105 cases of hand tumor were treated surgically and the results of clinical observation were as follows ; l. Among 105 cases, benign tumor was 101 cases(96.2%) Bone origin tumor was 20 cases, in which enchondroma and enchondromatosis were 17 cases(70%). Soft tissue origin tumor was 85 cases, in which ganglion was 54 cases(63.5%). 2. Among 105 cases, 42 cases were male and 63 cases were female. In age distribution, it showed even distribution. 3. In the duration of wymptom, 51 cases were below 1 year(48.6%). 4. The tumor occured 85 cases in soft tissue, 14 in phalanx, 7 in metacarpal and 1 in carpal bone. 5. The tumors were treated by excision or curettage and bone graft with good improvement, but postoperatively recurred in 2 cases of Hemangioma. Ampuation was performed in 3 cases of malignant tumors without recurrence.
Age Distribution ; Carpal Bones ; Chondroma ; Clinical Study ; Curettage ; Early Diagnosis ; Enchondromatosis ; Female ; Ganglion Cysts ; Hand ; Hemangioma ; Humans ; Male ; Pathology ; Recurrence ; Transplants

As South Korea becomes a super-aged society by 2025, the number of patients with Parkinson’s disease (PD) is increasing rapidly. PD is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity, and non-motor symptoms, such as depression, cognitive impairment, and autonomic nervous system disorders. The pathophysiology of dysphagia in PD is a complex interplay of motor disorders caused by dopamine deficiency in the basal ganglia and the involvement of the brainstem swallowing center and the peripheral nerve system affected by the PD pathology. Dysphagia in PD presents difficulties in taking medications, contributes to malnutrition and dehydration, and reduces the overall quality of life. Despite dysphagia being a prevalent problem in PD, a significant number of patients remain unaware of the swallowing difficulties. Therefore, healthcare practitioners need to understand dysphagia in PD, consider early screening and objective evaluations, and proactively implement swallowing treatment and compensatory therapy as needed. This review examines the pathophysiology, clinical characteristics, screening and diagnosis, and severity assessment of dysphagia in PD.

As South Korea becomes a super-aged society by 2025, the number of patients with Parkinson’s disease (PD) is increasing rapidly. PD is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity, and non-motor symptoms, such as depression, cognitive impairment, and autonomic nervous system disorders. The pathophysiology of dysphagia in PD is a complex interplay of motor disorders caused by dopamine deficiency in the basal ganglia and the involvement of the brainstem swallowing center and the peripheral nerve system affected by the PD pathology. Dysphagia in PD presents difficulties in taking medications, contributes to malnutrition and dehydration, and reduces the overall quality of life. Despite dysphagia being a prevalent problem in PD, a significant number of patients remain unaware of the swallowing difficulties. Therefore, healthcare practitioners need to understand dysphagia in PD, consider early screening and objective evaluations, and proactively implement swallowing treatment and compensatory therapy as needed. This review examines the pathophysiology, clinical characteristics, screening and diagnosis, and severity assessment of dysphagia in PD.

As South Korea becomes a super-aged society by 2025, the number of patients with Parkinson’s disease (PD) is increasing rapidly. PD is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity, and non-motor symptoms, such as depression, cognitive impairment, and autonomic nervous system disorders. The pathophysiology of dysphagia in PD is a complex interplay of motor disorders caused by dopamine deficiency in the basal ganglia and the involvement of the brainstem swallowing center and the peripheral nerve system affected by the PD pathology. Dysphagia in PD presents difficulties in taking medications, contributes to malnutrition and dehydration, and reduces the overall quality of life. Despite dysphagia being a prevalent problem in PD, a significant number of patients remain unaware of the swallowing difficulties. Therefore, healthcare practitioners need to understand dysphagia in PD, consider early screening and objective evaluations, and proactively implement swallowing treatment and compensatory therapy as needed. This review examines the pathophysiology, clinical characteristics, screening and diagnosis, and severity assessment of dysphagia in PD.

As South Korea becomes a super-aged society by 2025, the number of patients with Parkinson’s disease (PD) is increasing rapidly. PD is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity, and non-motor symptoms, such as depression, cognitive impairment, and autonomic nervous system disorders. The pathophysiology of dysphagia in PD is a complex interplay of motor disorders caused by dopamine deficiency in the basal ganglia and the involvement of the brainstem swallowing center and the peripheral nerve system affected by the PD pathology. Dysphagia in PD presents difficulties in taking medications, contributes to malnutrition and dehydration, and reduces the overall quality of life. Despite dysphagia being a prevalent problem in PD, a significant number of patients remain unaware of the swallowing difficulties. Therefore, healthcare practitioners need to understand dysphagia in PD, consider early screening and objective evaluations, and proactively implement swallowing treatment and compensatory therapy as needed. This review examines the pathophysiology, clinical characteristics, screening and diagnosis, and severity assessment of dysphagia in PD.

No abstract available.

The antihypertensive effects of diltiazem was observed in 30 cases of essential hypertension, and following results were obtained. 1) Mean decrease in systolic and diastolic blood pressure by oral diltiazem was 42.0+/-2.5mmHg and 17.8+/-1.7mmHg. The results of antihypertensive therapy revealed good control in 50% fair control in 30% poor in 17% and failure in 3% of the cases. In 80% of the cases, good or fair control of Hypertension which means drop of diastolic pressure to the level of less than 100mmhg was observed. 2) Mean drop in heart rate was 21+/-2 beats/min. 3) Daily dose was 90-180mg. 4) The side effect of oral Diltiazem was mild headache and dizziness, respectively one case.
Blood Pressure ; Diltiazem* ; Dizziness ; Headache ; Heart Rate ; Hypertension

Parkinson's disease (PD) is a neurodegenerative disorder characterized by typical motor symptoms such as resting tremor, bradykinesia, and rigidity, as well as non-motor manifestations, including psychiatric symptoms, autonomic dysfunction, and cognitive impairment. These symptoms induce a marked impact on functional independence in daily activities and quality of life in PD patients. Recent guidelines recommend adequate rehabilitation education and treatment from the early stages of PD, and rehabilitation has become part of standard care for PD. In Korea, the number of patients with PD has more than tripled over 15 years, from 39,265 in 2004 to 125,607 in 2019. However, the rehabilitation usage of PD patients has not changed remarkably, and it remains suboptimal in Korea compared to several developed countries, which have advanced and disseminated guidelines and implemented specialized care delivery systems for PD over the past 20 years. Additional efforts are warranted to provide adequate rehabilitation therapies for PD patients in Korea.

No abstract available.
Coronary Vessels* ; Pulmonary Artery*

PURPOSE: Recently, vancomycin-resistant enterococci (VRE) have become one of the major nosocomial pathogens in Korea. However, there have been few studies on the epidemiology of VRE colonization among neonates. In this study, we investigated the prevalence of VRE colonization, risk factors for VRE, and how to control the spread of VRE infection in the Neonatal Intensive Care Unit (NICU) of Pusan National University Hospital (PNUH). METHODS: We retrospectively reviewed medical records of 192 neonates who were admitted to the NICU of PNUH from March 2006 to March 2007. Surveillance cultures from rectal swabs for detecting VRE were obtained weekly during the study period. We analyzed the prevalence of VRE and various risk factors. RESULTS: The rate of VRE colonization among NICU patients was 25% (48/192). Thirty five of these VRE colonized patients were transferred to the NICU from other local hospitals. Compared with the non-VRE group, the risk factors associated with VRE colonization were lower birth weight, congenital heart disease, applied mechanical ventilation, use of a central venous catheter, chest tubing, a history of surgery, and use of antibiotics. CONCLUSION: VRE colonization among patients admitted to the NICU is rapidly increasing. Monitoring and managing premature neonates from the beginning of the birth process, avoiding many invasive procedures, avoiding antibiotics such as vancomycin and third generation cephalosporin are important for preventing the emergence and spread of VRE colonization in the NICU.
Anti-Bacterial Agents ; Birth Weight ; Central Venous Catheters ; Colon ; Heart Diseases ; Humans ; Infant ; Infant, Newborn ; Intensive Care, Neonatal ; Korea ; Medical Records ; Parturition ; Prevalence ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; Thorax ; Vancomycin ; Vancomycin Resistance